Effect of Iron-Chelator Deferiprone on the In Vitro Growth of Staphylococci
Open Access
- 1 January 2009
- journal article
- Published by Korean Academy of Medical Sciences in Journal of Korean Medical Science
- Vol. 24 (2), 289-295
- https://doi.org/10.3346/jkms.2009.24.2.289
Abstract
Kim CM, et al. J Korean Med Sci. 2009 Apr;24(2):289-295. http://dx.doi.org/10.3346/jkms.2009.24.2.289Keywords
This publication has 46 references indexed in Scilit:
- Ferrophilic Characteristics ofVibrio vulnificusand Potential Usefulness of Iron Chelation TherapyThe Journal of Infectious Diseases, 2007
- Iron Mobilization From Transferrin And Non-Transferrin-Bound-Iron by Deferiprone. Implications in the Treatment of Thalassemia, Anemia of Chronic Disease, Cancer and Other ConditionsHemoglobin, 2006
- Iron and infection: competition between host and microbes for a precious elementBest Practice & Research Clinical Haematology, 2002
- Identification of in vivo expressed vaccine candidate antigens from Staphylococcus aureusProceedings of the National Academy of Sciences of the United States of America, 2002
- Development of a Pharmaceutical Apotransferrin Product for Iron Binding TherapyBiologicals, 2001
- Iron Metabolism in Pathogenic BacteriaAnnual Review of Microbiology, 2000
- DeferiproneDrugs, 1999
- Changes in transferrin saturation after treatment with the oral iron chelator deferiprone in patients with iron overload.Journal of Clinical Pathology, 1995
- Inhibition of bacterial multiplication by the iron chelator deferoxamine: Potentiating effect of ascorbic acidEuropean Journal of Clinical Microbiology & Infectious Diseases, 1983
- Synergy between the iron chelator deferoxamine and the antimicrobial agents gentamicin, chloramphenicol, cefalothin, cefotiam and cefsulodinEuropean Journal of Clinical Microbiology & Infectious Diseases, 1983